When considering the longest-living creatures on Earth, the Greenland shark often comes to mind for its remarkable lifespan exceeding 250 years. Yet, bats, though far smaller and less conspicuous, also boast impressive longevity. Certain species can live for up to 25 years, a duration comparable to roughly 180 human years.
Even more fascinating is their near-complete immunity to cancer, a disease that typically becomes more prevalent with age and cell division in most animals. Recent research from the University of Rochester (UR) sheds light on how bats achieve this remarkable feat and what their biology could reveal about human cancer prevention and treatment.
The Longevity-Cancer Paradox in Bats
It is well established in biology that longer-lived animals tend to accumulate more cellular damage over time, increasing their risk of cancer. This is due to the greater number of cell divisions and prolonged exposure to environmental and internal stressors that can cause mutations.
However, bats defy this trend. Despite their extended lifespans, both wild and captive bats rarely develop tumors. This paradox has intrigued scientists and prompted detailed investigations into the molecular and cellular defenses bats use to avoid cancer.
The UR research team, led by biologists Vera Gorbunova and Andrei Seluanov, focused on four bat species: the little brown bat, the big brown bat, the cave nectar bat, and the Jamaican fruit bat.
Their findings, published recently in Nature Communications, reveal a sophisticated combination of genetic, cellular, and immune system adaptations that collectively protect bats from cancer.
The p53 Gene: Bats’ Cancer-Fighting Guardian
Central to bats’ cancer resistance is the tumor-suppressor gene known as p53. This gene plays a vital role in monitoring DNA integrity and triggering apoptosis—the programmed death of damaged cells that could otherwise become cancerous.
In humans, p53 is often called the “guardian of the genome” because of its critical role in preventing tumor formation. However, mutations in the human p53 gene are found in about 50% of cancers, undermining its protective function.
Remarkably, the little brown bat, a species native to Rochester and surrounding regions, carries two copies of the p53 gene, unlike humans who have only one. This duplication leads to elevated p53 activity, enabling bats to efficiently detect and eliminate potentially dangerous cells before they develop into tumors.
The bats’ enhanced p53 function is finely balanced; too much p53 activity can be harmful by killing excessive healthy cells, but bats have evolved mechanisms to maintain this equilibrium, ensuring effective cancer suppression without damaging normal tissues.
This phenomenon is not unique to bats. Elephants, another long-lived species, also possess multiple copies of the p53 gene, which contributes to their low cancer rates despite their large size and long lives. The UR researchers hypothesize that bats have similarly evolved enhanced p53 activity as an additional layer of cancer defense.
Read more: Scientists Discover Animals Have a Mysterious ‘Sixth Sense’, Changing Evolutionary Theories
Telomerase Activity and Cellular Aging
Another key factor in bats’ longevity and cancer resistance lies in their management of telomerase, an enzyme that maintains the protective caps (telomeres) at the ends of chromosomes. In most mammals, telomerase activity is limited, causing telomeres to shorten with each cell division.
When telomeres become too short, cells enter a state called replicative senescence, ceasing to divide. While senescence acts as a barrier against uncontrolled cell growth, it also promotes chronic inflammation, which contributes to aging and age-related diseases.
Bats exhibit active telomerase expression, which allows their cells to divide indefinitely without entering senescence. This capacity supports tissue regeneration and repair throughout their long lives.
Although unlimited cell division is often associated with cancer risk, bats’ high p53 activity acts as a counterbalance, eliminating any cells that begin to proliferate abnormally. This interplay between telomerase and p53 activity helps bats maintain cellular health and longevity.
Unique Immune System Adaptations
Bats are also renowned for their exceptional immune systems, which enable them to harbor and tolerate numerous viruses that are lethal to humans, including coronaviruses and Ebola. The UR study highlights that bats’ immune adaptations may also contribute to their cancer resistance.
Their immune systems can recognize and eliminate tumor cells, while simultaneously controlling inflammation—a process that, if unchecked, can promote cancer development.
As humans age, immune function typically declines, and chronic inflammation increases, both of which raise cancer risk. Bats, however, appear to regulate inflammation effectively, maintaining immune vigilance without harmful overactivation. This finely tuned immune response not only protects bats from viral infections but may also suppress cancer initiation and progression.
Oncogenic Hits: Bats’ Vulnerability and Defense
Cancer arises when normal cells accumulate multiple genetic mutations, or “oncogenic hits,” that disrupt regulatory pathways controlling cell growth and death. In humans, it often takes several such hits for a cell to become malignant.
Surprisingly, the UR researchers found that bat cells require only two oncogenic hits to transform into cancerous cells, indicating that bats are not inherently resistant to cancer at the cellular level.
Instead, bats rely on robust tumor-suppressor mechanisms, such as enhanced p53 activity and immune surveillance, to prevent cancer from developing despite this vulnerability.
This means that while bat cells can become cancerous under certain conditions, their bodies are exceptionally well-equipped to detect and eliminate these cells before tumors form.
Read more: Newly Discovered Dinosaur Species Rewrites The T. Rex Family Tree
Genetic Insights: DNA Repair and Tumor Suppression
Beyond p53 and telomerase, bats exhibit evolutionary adaptations in other genes related to DNA repair and tumor suppression. Comparative genomic studies have identified positive selection in several DNA repair genes in bats, including PALB2, a key player in homologous recombination repair, which fixes dangerous DNA breaks accurately.
Other DNA polymerase genes involved in DNA replication and repair also show bat-specific changes, suggesting enhanced genomic maintenance capabilities. These adaptations likely contribute to bats’ ability to prevent mutations that could lead to cancer.
Interestingly, while some well-known tumor suppressors like BRCA2 do not show strong selection signals, bats possess unique genetic variations that may fine-tune their cancer defenses.
Translating Bat Biology to Human Therapies
The discoveries about bats’ cancer resistance have important implications for human medicine. Enhancing p53 activity is already a target in some experimental cancer therapies, and understanding how bats modulate this gene without adverse effects could guide safer and more effective treatments.
Similarly, insights into bats’ telomerase regulation and immune system balance may inform strategies to promote tissue regeneration and control inflammation in aging humans, reducing cancer risk and improving overall health.
However, translating findings from bats to humans requires caution. For example, the p53 gene regulatory network differs significantly between species, and what works in bats or model organisms like mice may not directly apply to humans. Nonetheless, bats provide a valuable natural model for studying cancer resistance and longevity.
Read more: You Can Now Talk To Dolphins In Real Time Thanks To Google’s Brand New Tech
Conclusion
Bats, often overlooked nocturnal mammals, harbor a suite of biological adaptations that enable them to live long, healthy lives with minimal cancer risk.
Their enhanced p53 gene activity, active telomerase expression, unique immune system, and evolved DNA repair mechanisms form a multi-layered defense against cancer. While bats are not immune to cancer at the cellular level, their powerful tumor-suppressor systems effectively prevent disease development.
As scientists continue to explore these mechanisms, bats offer a promising blueprint for developing novel cancer therapies and anti-aging interventions for humans. By learning from nature’s own cancer fighters, we may unlock new paths to extending healthy human lifespans and conquering one of medicine’s greatest challenges.
